NCT01724736 - A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Pre Diabetic

Interventions

DRUG

Placebo

Celluose 10g - Matches the total dietary fiber content of NM504 as well as the color and taste. Subjects take 1 dose within 1h prior to either breakfast or lunch and a 2nd dose within 1h prior to the evening meal for 4 weeks.

DRUG

NM504:

Cobiotic formula of GRAS ingredients with a total dietary fiber content of 10g. Subjects take 1 dose within 1h prior to either breakfast or lunch and a 2nd dose within 1h prior to the evening meal for 4 weeks.

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge